Department of Cardiovascular Sciences, Sapienza University, Rome, Italy.
Interventional Cardiology Unit, San Filippo Neri Hospital, Rome, Italy.
Am J Med. 2020 Jan;133(1):73-83.e4. doi: 10.1016/j.amjmed.2019.05.048. Epub 2019 Jun 29.
The long-term mortality of patients with myocardial infarction and nonobstructed coronary arteries (MINOCA) remains poorly defined. This study aimed to determine the long-term mortality of patients with MINOCA and to identify potential prognostic determinants of long-term outcome.
We searched PubMed, EMBASE, and Cochrane databases and reviewed cited references up to December 31, 2018 to identify studies with >6 months' follow-up data.
We selected 44 studies including 36,932 patients (20,052 women and 16,880 men). During a median follow-up of 25 months (interquartile range: 23-39 months), 1409 patients had died (3.8%). Overall, annual mortality rate was 2.0% (95% confidence interval [CI]: 1.5% to 2.4%), with significant heterogeneity (I = 80%, P < .001). Meta-analysis of the 26 studies comparing patients with MINOCA with those with myocardial infarction and obstructive coronary artery disease showed that annual rates of long-term total mortality were 2.2% (95% CI: 1.7% to 2.7%) and 5.0% (95% CI: 4.1% to 5,9%), respectively, with a significant difference between the two groups (relative risk: 0.60, 95% CI: 0.46 to 0.78, P < .001). Meta-regression analysis demonstrated that normal ejection fraction (P ≤ .0001) and normal coronary arteries at angiography (P = .004) were inversely related to long-term mortality, whereas use of beta-blockers during follow-up (P = .010) and ST depression on the admission electrocardiogram (P = .016) were directly related with worse outcome.
The long-term mortality after MINOCA is lower than that in patients with myocardial infarction and obstructive coronary artery disease, but it is not trivial. Reduced ejection fraction, nonobstructive coronary artery disease, use of beta-blockers during follow up and ST depression on the admission electrocardiogram are significant predictors of long-term prognosis.
无阻塞性冠状动脉疾病心肌梗死(MINOCA)患者的长期死亡率仍不清楚。本研究旨在确定 MINOCA 患者的长期死亡率,并确定长期预后的潜在预测因素。
我们检索了 PubMed、EMBASE 和 Cochrane 数据库,并查阅了截至 2018 年 12 月 31 日的参考文献,以确定有超过 6 个月随访数据的研究。
我们选择了 44 项研究,共纳入 36932 例患者(20052 例女性和 16880 例男性)。在中位随访 25 个月(四分位间距:23-39 个月)期间,有 1409 例患者死亡(3.8%)。总体而言,年死亡率为 2.0%(95%可信区间[CI]:1.5%-2.4%),且存在显著异质性(I=80%,P<.001)。对比较 MINOCA 患者与心肌梗死伴阻塞性冠状动脉疾病患者的 26 项研究进行的荟萃分析显示,长期总死亡率的年发生率分别为 2.2%(95%CI:1.7%-2.7%)和 5.0%(95%CI:4.1%-5.9%),两组之间差异显著(相对风险:0.60,95%CI:0.46-0.78,P<.001)。Meta 回归分析表明,射血分数正常(P≤.0001)和冠状动脉造影正常(P=.004)与长期死亡率呈负相关,而随访期间使用β受体阻滞剂(P=.010)和入院心电图 ST 段压低(P=.016)与预后不良呈正相关。
MINOCA 后的长期死亡率低于心肌梗死伴阻塞性冠状动脉疾病患者,但并非微不足道。射血分数降低、非阻塞性冠状动脉疾病、随访期间使用β受体阻滞剂和入院心电图 ST 段压低是长期预后的显著预测因素。